FDA | LawsuitInformation.org | Pharmaceutical Product Liability

Archive for the ‘FDA’ Category:

Drug Headlines of 2011

Published on January 21, 2012 by Scott G. in *Featured, FDA, General Drug News & Safety

Posted December 20, 2011 by The Scientist A list of this year’s newsworthy successes—and failures—in drug development Developing new medicines is tricky business, requiring sound science, regulatory savvy, and marketing skills. The past year has seen success and failure in all these realms. Here, The Scientist recounts some of the noteworthy drug developments of 2011. Notable Drug Approvals: First new lupus drug in 52 years After more than 18 years of development, the US Food and Drug Administration (FDA) approved the first drug to treat lupus in more than a half-century. Benlysta (belimumab) is a human monoclonal antibody, produced by Human Genome Sciences and GlaxoSmithKline, that cuts B-cells proliferation, a proposed mechanism underlying the autoimmune

[Continue Reading]

Comments Off

Drug Approvals Up for 2011

Published on January 20, 2012 by Scott G. in FDA, General Drug News & Safety

Posted January 9, 2012 by The Scientist The FDA approved 30 drugs last year, the highest number in the last 7 years. The US Food and Drug Administration approved 30 drugs in 2011, compared with 21 in 2010, according to an analysis by Bloomberg News. That number is the highest since 36 drugs were approved in 2004. Some of the headline drugs to get the green light include Yervoy, a drug that primes the immune system to attack melanoma; Xarelto, which reduces clotting for patients with irregular heartbeats; and Benlysta, the first lupus drug approved in 50 years. The FDA toughened its data requirements in 2007, after critics faulted its response to claims of heart

[Continue Reading]

Comments Off

J&J, C.R. Bard Must Study Safety of Vaginal Mesh, FDA Says

Published on January 20, 2012 by Scott G. in *Featured, FDA, Kugel & Transvaginal Mesh

Posted January 5, 2012 by Bloomberg Johnson & Johnson (JNJ) and C.R. Bard Inc. (BCR) must study rates of organ damage and complications linked to vaginal mesh implants, U.S. regulators said, responding to patient advocates who say the devices have harmed women. The Food and Drug Administration wrote J&J, C.R. Bard and 31 other manufacturers, telling them to conduct three years of trials on safety and effectiveness, the agency’s William Maisel said yesterday in a telephone interview. An FDA report in July found a fivefold jump in deaths, injuries or malfunctions tied to the products. Almost 300,000 synthetic meshes were implanted in U.S. women in 2010 to treat incontinence or shore up pelvic muscles, the

[Continue Reading]

Comments Off

Lights Out for Bayer’s YAZ?

Published on January 19, 2012 by Scott G. in FDA, Yaz

Posted January 6, 2012 by InjuryBoard Bayer AG, Germany’s largest drugmaker, blinked and swallowed hard, at the end of December, when it begged the Court overseeing the YAZ litigation. ayer managed to avoid the first trial which was set to start January 9th, over claims its birth-control pills caused blood clots after Judge Hearndon appointed a mediator in hopes of settling the cases. The plaintiffs were opposed to the setting of a mediator and wanted their day in court. Mediation Ordered U.S. District Judge David Herndon in Illinois postponed the January 9th trial of a lawsuit which alleged that Bayer mislead women about the health risks of its Yasmin family of birth-control pills. The case

[Continue Reading]

Comments Off

FDA Announces 10 Drugs With Severe Birth Defect Warnings

Published on January 19, 2012 by Scott G. in *Featured, Antidepressant, Birth Defects, Darvocet, FDA, Heart Risk, Paxil, Prozac, SSRI, Zoloft

Posted January 10, 2012 by SB Wire San Diego, CA — (SBWIRE) — 01/10/2012 – The drugs found on this list went through multiple tests, research experiments, and survey before the FDA classified them as dangerous to babies during pregnancy. Zoloft (sertraline), a popular antidepressant known as a “selective serotonin reuptake inhibitor” (SSRI), is linked to dangerous side effects in users and serious birth defects (including, heart murmur, hole in the heart and other serious heart defects) if taken by pregnant women. Since 2006, the FDA has warned against the use of Zoloft and other SSRIs in pregnant mothers. Paxil (paroxetine), one of the most widely prescribed SSRI’s for depression in adults has also been

[Continue Reading]

Comments Off

Antidepressants Used By 11 Percent of Americans

Published on December 23, 2011 by Scott G. in *Featured, Antidepressant, FDA, Paxil, Prozac, SSRI, Zoloft

Posted December 22, 2011 by Seattle Times The woman leaning against a pillar didn’t know more Americans — twice as many — take antidepressants than go to movie theaters weekly. She hadn’t heard that a federal study found the meds are used by 23 percent of middle-aged women — almost one in four. But she knows Prozac. “Good stuff,” she said, remembering how it helped her deal with a splintering marriage. Data released by the U.S. Centers for Disease Control and Prevention in November showed that 11 percent of Americans ages 12 and older used Prozac, Zoloft, Paxil or other antidepressants. Women were prescribed the pills more than men, according to national surveys that asked

[Continue Reading]

Comments Off

United States Joint Committee Wants Limit on the Use of Vaginal Mesh Products

Published on December 23, 2011 by Scott G. in FDA, Kugel & Transvaginal Mesh

Posted December 21, 2011 by EmailWire A Joint Committee issued by the American College of Obstetricians and Gynecologists (ACOG) and the American Urogynecologic Society (AUGS) recommends limiting the use of vaginal mesh to high-risk women only. (EMAILWIRE.COM, December 21, 2011 ) LegalView, a leading online legal resource, supports a Joint Committee Opinion issued by the American College of Obstetricians and Gynecologists (ACOG) and the American Urogynecologic Society (AUGS) which recommends limiting the use of trans vaginal mesh to high-risk women. Vaginal mesh is a surgical device implanted in women who have experienced a pelvic organ prolapse or suffer from incontinence, yet for most women, mesh complications may cause additional problems. High-risk women who receive the

[Continue Reading]

Comments Off

Dangerous Injuries Caused by Transvaginal Meshes and Other Pelvic Mesh Bladder Slings

Published on December 23, 2011 by Scott G. in FDA, Kugel & Transvaginal Mesh

Posted December 23, 2011 by InjuryBoard Sometimes as we age, our bodies don’t function like they once did. Women of any age can experience pelvic organ prolapse (POP) which causes pelvic organs to fall into the vaginal wall(s) causing discomfort, difficulty urinating and other problems. Specifically, women who have gone through a difficult delivery or have delivered a large baby may experience such a problem. Some time ago, various manufacturers developed a product to assist women experiencing this problem – a mesh to hold the pelvic organs in the proper place. The following is a list of such mesh products: Boston Scientific Uphold and Pinnacle Pelvic Floor Repair Kits, Gynecare (Ethicon) Prolift Anterior, Perigee and

[Continue Reading]

Comments Off

FDA Issues New Warnings About Risks of Vaginal Mesh

Published on November 21, 2011 by Scott G. in FDA, Kugel & Transvaginal Mesh

Posted November 5, 2011 by 24-7 PR Recent warnings and requests by consumer advocates to recall vaginal mesh highlight the dangers of the transvaginal placement of surgical mesh. The costs to patients may far outweigh any benefits and the FDA is warning doctors to fully inform patients of the risks prior to completing TVM surgery. November 05, 2011 /24-7PressRelease/ – Warning that the risks outweigh the benefits of the transvaginal placement of surgical mesh, the Food and Drug Administration (FDA) advised potential patients to fully consider all options and risks before undergoing the procedure to correct pelvic organ prolapsed (POP) or stress urinary incontinence (SUI). Among the risks of transvaginal mesh (TVM) is the possibility

[Continue Reading]

Comments Off

Judge Blocks Confidential Yaz Litigation Files from Going to FDA

Published on November 18, 2011 by Scott G. in FDA, Yaz

Posted November 17, 2011 by About Lawsuits A federal judge has rejected the request of a woman who wants to show federal health regulators certain protected documents that were obtained during discovery in the Yasmin and Yaz litigation, despite the plaintiff’s indication that the “confidential” internal documents may reveal important safety information about the controversial birth control pills that the FDA may not already have. Kaitlyn Dietrick, one of thousands of women who have filed a Yaz lawsuit or Yasmin lawsuit against Bayer Healthcare over failure to warn about side effects of their birth control pills, attempted to get about two dozen confidential documents unsealed so that they could be presented at an upcoming FDA

[Continue Reading]

Comments Off

« Older Entries

Archive for the ‘FDA’ Category:

Drug Headlines of 2011

Drug Approvals Up for 2011

J&J, C.R. Bard Must Study Safety of Vaginal Mesh, FDA Says

Lights Out for Bayer’s YAZ?

FDA Announces 10 Drugs With Severe Birth Defect Warnings

Antidepressants Used By 11 Percent of Americans

United States Joint Committee Wants Limit on the Use of Vaginal Mesh Products

Dangerous Injuries Caused by Transvaginal Meshes and Other Pelvic Mesh Bladder Slings

FDA Issues New Warnings About Risks of Vaginal Mesh

Judge Blocks Confidential Yaz Litigation Files from Going to FDA

Popular Posts

Sponsored Links

Pharmaceutical Categories

Law Blogs & Legal News